[1]
“Targeting Immune Checkpoints in Oncology: Advances and Limitations in Immunotherapeutic Strategies”, Ind-Am. J Pharm. Bio. Sci., vol. 23, no. 1, pp. 45–57, Jan. 2025, doi: 10.62646/.